Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis

Figure 1 Overall survival rate (A) and time to disease progression (B) of the patients. OS: Overall survival; TTP: Time to disease progression.

Figure 2 Overall survival of the objective response and disease control groups. A, B: After the second cycle of high-dose hepatic arterial infusion chemotherapy (HAIC); C, D: During HAIC.

Figure 3 Cumulative survival rate according to the presence of extrahepatic metastasis.

Figure 4 Cumulative survival rates. A: According to the pre-treatment α-fetoprotein (AFP) level; B: According to the AFP reduction after two cycles of hepatic arterial infusion chemotherapy (HAIC); C: According to the pre-treatment protein induced by vitamin K absence or antagonist (PIVKA)-II level; D: According to the PIVKA-II reduction after two cycles of HAIC.